Lataa...
Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation
BACKGROUND: There is a correlation between tumor and inflammation. The activity of 13-[CH(2)CO-Cys(Bzl)-OBzl]-berberine (13-Cys-BBR) slowing tumor growth is higher than that of BBR. Whether the anti-inflammation activity of 13-Cys-BBR is higher than that of BBR remains unknown. There is a correlatio...
Tallennettuna:
| Julkaisussa: | Drug Des Devel Ther |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7276341/ https://ncbi.nlm.nih.gov/pubmed/32581515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S249228 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|